Goldenwell Biotech, Inc. (GWLL) stock
GWLLOTCFood and Kindred ProductsFiscal year ends December 31
$0.65+0.05 (+8.33%)
Close on Oct 19, 2026Market cap $64.35MP/E –Yield –
Goldenwell Biotech profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Goldenwell Biotech's profit margin for the twelve months ending Jun 30, 2026 was -512940.0%. For fiscal 2025 it was -539038.2%, against -94602.9% the year before. The highest annual figure on record is -732.6% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -539038.2% | −444435.3 |
| FY2024 | Dec 31, 2024 | -94602.9% | −88210.7 |
| FY2023 | Dec 31, 2023 | -6392.2% | −4331.3 |
| FY2022 | Dec 31, 2022 | -2060.9% | −1328.2 |
| FY2021 | Dec 31, 2021 | -732.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -363163.6% | −353350.6 |
| Q2 FY2024 | Jun 30, 2024 | -35913.7% | −33550.4 |
| Q4 FY2023 | Dec 31, 2023 | -7999.6% | −7989.1 |
| Q3 FY2023 | Sep 30, 2023 | -9268.6% | −8546.8 |
| Q2 FY2023 | Jun 30, 2023 | -9813.0% | −1405.0 |
| Q1 FY2023 | Mar 31, 2023 | -2363.3% | −1761.3 |
| Q3 FY2022 | Sep 30, 2022 | -10.5% | +135.5 |
| Q2 FY2022 | Jun 30, 2022 | -721.8% | +1410.6 |
| Q1 FY2022 | Mar 31, 2022 | -8408.1% | – |
| Q4 FY2021 | Dec 31, 2021 | -602.0% | – |
| Q3 FY2021 | Sep 30, 2021 | -145.9% | – |
| Q2 FY2021 | Jun 30, 2021 | -2132.4% | – |
See a number that looks wrong?